Sirnaomics Ltd. operates as a holding company, which engages in research and development of clinical drugs. It is also involved in the development and manufacturing of RNA interference therapeutics. Its product pipeline includes STP705, STP707, RV-1730, and GalAhead. The company was founded by Yang Lu on October 15, 2020 and is headquartered in Hong Kong.